Skip to main content
. 2018 Dec 19;219(11):1735–1742. doi: 10.1093/infdis/jiy726

Figure 2.

Figure 2.

Pharmacokinetic decay of long-acting intramuscular maintenance doses of cabotegravir and rilpivirine with and without 600 mg once-daily rifampicin. A, 400 mg cabotegravir every 4 weeks. B, 600 mg cabotegravir every 8 weeks. C, 600 mg rilpivirine every 4 weeks D, 900 mg rilpivirine every 8 weeks. Abbreviations: CAB, cabotegravir; RIF, rifampicin; RPV, rilpivirine.